- Drug Manufacturers - Specialty & Generic
- Healthcare
Viatris Inc.
VTRS · US ·
NASDAQ
11.4
USD
-0.17
(1.49%)
-
-0.54
EPS
-
-21.00
P/E
-
13.6B
MARKET CAP
-
4.21%
DIV YIELD
EPS Estimates
2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | CAGR | |
---|---|---|---|---|---|---|
High Estimate | -0.521 | 2.71 | 0.83 | 0.87 | 2.85 | 65.30% |
Avg. Estimate | -0.54 | 2.69 | 0.636 | 0.657 | 2.74 | 63.07% |
Low Estimate | -0.562 | 2.67 | 0.22 | 0.37 | 2.64 | 60.91% |
No. Of Analysts | 5 | 6 | 5 | 3 | 1 |
Revenue Estimates
2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | CAGR | |
---|---|---|---|---|---|---|
High Estimate | 15.3B | 15.3B | 14.9B | 15.1B | 17.1B | 2.79% |
Avg. Estimate | 15.2B | 14.9B | 14.6B | 14.7B | 16.6B | 2.11% |
Low Estimate | 15.2B | 14.6B | 14.2B | 14.3B | 16.1B | 1.49% |
No. Of Analysts | 5 | 5 | 6 | 5 | 2 |
Net Income Estimates
2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | CAGR | |
---|---|---|---|---|---|---|
High Estimate | 1.69B | 3.28B | 1B | 1.05B | 3.44B | 19.37% |
Avg. Estimate | -646M | 3.25B | 667M | 784M | 3.31B | 63.32% |
Low Estimate | -2.99B | 3.23B | 266M | 447M | 3.19B | 32.35% |
No. Of Analysts | 5 | 5 | 6 | 5 | 2 |